Harish Shantharam insider trades

Open-market stock purchases and sales by Harish Shantharam, Chief Financial Officer at ALX Oncology Holdings Inc, from SEC Form 4 filings since May 22, 2023.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +53%.

Recent trades

DateStockTradeValue
Jan 26, 2026ALXO ALX Oncology Holdings IncBought (not open market)—

Companies traded

  • ALXO ALX Oncology Holdings Inc: 1 buy, last Jan 26, 2026
  • CBAY CymaBay Therapeutics, Inc: other filings, last Mar 22, 2024

Get free alerts when Harish Shantharam files a new trade →